Clinical decision making can be driven by patient preference, and the undoubted advantages of the new insulin analogs in reducing hypoglycemic risk and facilitating a more normal lifestyle in women with longstanding type 1 diabetes have often overridden medical caution in a pregnant woman’s personal choice.